Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-05-15
2007-05-15
Rao, Deepak (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S263400, C514S275000, C514S304000, C544S277000, C544S330000, C546S124000, C546S125000, C546S126000
Reexamination Certificate
active
10470561
ABSTRACT:
Compounds represented by Formula (I): (I) or pharmaceutically acceptable salts thereof, are effective as NMDA NR2B antagonists useful for relieving pain
REFERENCES:
patent: 3184462 (1965-05-01), Scarborough et al.
patent: 5807855 (1998-09-01), Bøgesø, et al.
patent: 6124323 (2000-09-01), Bigge et al.
patent: WO 84/01151 (1984-03-01), None
XP-002201030—L. Zhou, et al.,J. Med. Chem., 42, pp. 2993-3000 (1999).
Butcher John W.
Claiborne Christopher F.
Claremon David A.
Libby Brian E.
Liverton Nigel J.
Camara Valerie J.
Merck & Co. , Inc.
Rao Deepak
Yang Mollie M.
LandOfFree
N-substituted nonaryl-heterocyclic NMDA/NR2B antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with N-substituted nonaryl-heterocyclic NMDA/NR2B antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and N-substituted nonaryl-heterocyclic NMDA/NR2B antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3813764